It is known that increased ROS production during heart failure is accompanied by reduced antioxidant mechanisms, i.e., decreased activities of SOD, CAT, and GPx, as well as the activation of the pro-inflammatory NF-κB [31,32]. The gene discussed is SOD1; the disease is heart failure.